No contraindication is listed in the UK Summary of Product Characteristics (SmPC), and no clinically relevant pharmacokinetic interactions are expected
The article cites a BMI of 30 or higher, or a BMI of 27 to 29.9 paired with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or cardiovascular disease
If you have TRICARE and want coverage for weight loss medication, you may want to consider Wegovy (semaglutide), Zepbound (tirzepatide), Saxenda (liraglutide), Qsymia (phentermine-topiramate ER), phentermine, or Contrave
In January 2024, the FDA announced it was evaluation reports of hair loss and suicidal thoughts in patients taking Ozempic, Mounjaro, or Wegovy
The plates were kept at 80 C until shipment
They can help rule out other causes or adjust your treatment plan